🔎 Trials Near Me

Domov › Burkittov limfom › New Jersey

Klinične študije za Burkittov limfom v New Jersey

8 študij za Burkittov limfom išče udeležence na lokacijah v New Jersey.

Mesta v New Jersey

Uradno besedilo študije (angleško)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Jersey Shore Medical Center, Neptune City
  • in še 2
Vključevanje udeležencevFaza 2
366 Days – 46 Years · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick
  • in še 1
Vključevanje udeležencevFaza 2
365 Days · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • Hackensack Meridian Health, Hackensack
  • Carol G Simon Cancer Center, Morristown
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07648264

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick
Vključevanje udeležencevFaza 1/2
6 Months – 25 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Saint Peter's University Hospital, New Brunswick
  • in še 4
Vključevanje udeležencevFaza 2
Starost 1–30 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Jersey Shore Medical Center, Neptune City
  • in še 4
Vključevanje udeležencevFaza 3
365 Days – 25 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Regional Cancer Care Associates, Hackensack
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 13. feb. 2026 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • Hackensack University Medical Center, Hackensack
Vključevanje udeležencevFaza 2
Starost 1–25 · Vsi spoli · Posodobljeno 4. maj 2025 · NCT03509961

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.